📋 Tender Overview
Contract awarded for Providing medicines for national health programs { "detected_language": "romanian", "translated_text": "lot-0001, title: vutrisiran 25mg, description: vutrisiran 25mg pre-filled syringe according to specifications. the estimated value of the largest subsequent contract anticipated to be awarded during the framework agreement is 654,258.84 lei excluding vat. the estimated minimum and maximum quantities that may be requested during the entire framework agreement are found in the specifications. the awarding of subsequent contracts based on the framework agreements will be done monthly. lot-0002, title: ocrelizumab subcutaneous 920mg/23ml, description: ocrelizumab subcutaneous 920mg/23ml according to specifications. the estimated value of the largest subsequent contract anticipated to be awarded during the framework agreement is 667,696.64 lei excluding vat. the estimated minimum and maximum quantities that may be requested during the entire framework agreement are found in the specifications. the awarding of subsequent contracts based on the framework agreements will be done monthly. lot-0003, title: fingolimod 0.5mg, description: fingolimod 0.5mg tablets according to specifications. the estimated value of the largest subsequent contract anticipated to be awarded during the framework agreement is 135,212.00 lei excluding vat. the estimated minimum and maximum quantities that may be requested during the entire framework agreement are found in the specifications. the awarding of subsequent contracts based on the framework agreements will be done monthly. lot-0005, title: eltrombopag 25mg, description: eltrombopag 25mg film-coated tablets according to specifications. the estimated value of the largest subsequent contract anticipated to be awarded during the framework agreement is 50,794.80 lei excluding vat. the estimated minimum and maximum quantities that may be requested during the entire framework agreement are found in the specifications. the awarding of subsequent contracts based on the framework agreements will be done monthly. lot-0006, title: eltrombopag 50mg, description: eltrombopag 50mg tablets according to specifications. the estimated value of the largest subsequent contract anticipated to be awarded during the framework agreement is 101,136.00 lei excluding vat. the estimated minimum and maximum quantities that may be requested during the entire framework agreement are found in the specifications. the awarding of subsequent contracts based on the framework agreements will be done monthly. lot-0007, title: tenecteplase 5000ui, description: tenecteplase 5000ui vial according to specifications. the estimated value of the largest subsequent contract anticipated to be awarded during the framework agreement is 71,953.00 lei excluding vat. the estimated minimum and maximum quantities that may be requested during the entire framework agreement are found in the specifications. the awarding of subsequent contracts based on the framework agreements will be done monthly. lot-0008, title: everolimus 5mg, description: everolimus 5mg tablets according to specifications. the estimated value of the largest subsequent contract anticipated to be awarded during the framework agreement is 37,618.20 lei excluding vat. the estimated minimum and maximum quantities that may be requested during the entire framework agreement are found in the specifications. the awarding of subsequent contracts based on the framework agreements will be done monthly. lot-0009, title: insulin degludec, description: insulin degludec pre-filled pen according to specifications. the estimated value of the largest subsequent contract anticipated to be awarded during the framework agreement is 4,851.00 lei excluding vat. the estimated minimum and maximum quantities that may be requested during the entire framework agreement are found in the specifications. the awarding of subsequent contracts based on the framework agreements will be done monthly. lot-0010, title: insulin glargine, description: insulin glargine pre-filled pen according to specifications. the estimated value of the largest subsequent contract anticipated to be awarded during the framework agreement is 5,598.00 lei excluding vat. the estimated minimum and maximum quantities that may be requested during the entire framework agreement are found in the specifications. the awarding of subsequent contracts based on the framework agreements will be done monthly. lot-0012, title: insulin aspart, description: insulin aspart pre-filled pen according to specifications. the estimated value of the largest subsequent contract anticipated to be awarded during the framework agreement is 3,229.00 lei excluding vat. the estimated minimum and maximum quantities that may be requested during the entire framework agreement are found in the specifications. the awarding of subsequent contracts based on the framework agreements will be done monthly. lot-0018, title: tofersen 100mg, description: tofersen 100mg vial according to specifications. the estimated value of the largest subsequent contract anticipated to be awarded during the framework agreement is 606,418.20 lei excluding vat. the estimated minimum and maximum quantities that may be requested during the entire framework agreement are found in the specifications. the awarding of subsequent contracts based on the framework agreements will be done monthly. lot-0020, title: anti-lymphocyte immunoglobulin (calf) 50mg/ml, description: anti-lymphocyte immunoglobulin (calf) 50mg/ml according to specifications. the estimated value of the largest subsequent contract anticipated to be awarded during the framework agreement is 232,174.80 lei excluding vat. the estimated minimum and maximum quantities that may be requested during the entire framework agreement are found in the specifications. the awarding of subsequent contracts based on the framework agreements will be done monthly. lot-0021, title: estimated value excluding vat: 135129854.88 ron.Providing medicines for national health programs